This inventor holds 1 USPTO granted patent. Top assignee: Indiana University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations in Nerve Stimulation by Christian Phillip Vetter
Introduction
Christian Phillip Vetter is an accomplished inventor based in Lombard, IL (US). He has made significant contributions to the field of nerve stimulation technology. His innovative work focuses on the use of low-frequency alternating current for peripheral nerve activation and blocking.
Latest Patents
Vetter holds a patent titled "Peripheral nerve activation and blocking using cuff assembly and sinusoidal low frequency alternating current." This patent describes a method of nerve stimulation via a Low Frequency Alternating Current (LFAC) waveform. The technology allows for the blocking of action potential conduction, while an increase in LFAC frequency and/or amplitude can lead to nerve activation. The unique aspect of LFAC for nerve blocking is its frequency independence, which means that the threshold LFAC activation can decrease with increasing frequency. This innovation provides a way to selectively activate or block nerve fibers based on frequency and amplitude settings.
Career Highlights
Christian Phillip Vetter is affiliated with Indiana University, where he continues to advance research in nerve stimulation technologies. His work has the potential to impact various medical applications, particularly in pain management and neuromodulation.
Collaborations
Vetter has collaborated with notable colleagues, including Kenichi Yoshida and Michael Ryne Horn. These partnerships have contributed to the development and refinement of his innovative technologies.
Conclusion
Christian Phillip Vetter's contributions to nerve stimulation technology exemplify the intersection of innovation and medical science. His patent on LFAC technology represents a significant advancement in the field, with the potential to improve patient outcomes in nerve-related treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
